Background Studies have reported a significant association between non-alcoholic fatty liver
disease (NAFLD) and increased incidence of cardiovascular disease (CVD). However, the …

Hepatic steatosis is defined as pathologically elevated liver fat content and has many
underlying causes. Nonalcoholic fatty liver disease (NAFLD) is the most common chronic …

Opportunistic CT screening leverages robust imaging data embedded within abdominal and
thoracic scans that are generally unrelated to the specific clinical indication and have …

Background & Aims There have been many studies of the effects of non-alcoholic fatty liver
disease (NAFLD) and the risk of cardiovascular disease (CVD), but these have produced …

Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver
disease worldwide, and the progressive form of this condition, nonalcoholic steatohepatitis …

Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are both
manifestations of end-organ damage of the metabolic syndrome. Through multiple …

Hepatic steatosis is a frequently encountered imaging finding that may indicate chronic liver
disease, the most common of which is non-alcoholic fatty liver disease. Non-alcoholic fatty …

Abdominal CT is a frequently performed imaging examination for a wide variety of clinical
indications. In addition to the immediate reason for scanning, each CT examination contains …

Background Nonalcoholic fatty liver disease and its consequences are a growing public
health concern requiring cross-sectional imaging for noninvasive diagnosis and …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with insulin
resistance and metabolic syndrome. The spectrum of disease ranges from simple steatosis …